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ABSTRACT The mitogenic effects of brain and pituitary fibroblast growth factors (FGF) on
vascular endothelial cells derived from either human umbilical vein or bovine aortic arch have
been compared . Both brain and pituitary FGF are mitogenic for low density human umbilical
endothelial (HUE) cell cultures maintained on either fibronectin- or laminin-coated dishes or
on biomatrices produced by cultured cells such as bovine corneal endothelial cells or the
teratocarcinoma cell line PF-HR-9 . Pituitary FGF triggered the proliferation of HUE cells at
concentrations as low as 0.25 ng/ml, with a half-maximal response at 0.55 ng/ml and optimal
effect at 2 .5 to 5 ng/ml . It was 50,000-fold more potent than commercial preparations of
endothelial cell growth factor and 40 times more potent than commercial preparations of
pituitary FGF . Similar results were observed when the effect of pituitary FGF was tested on
low density cultures of adult bovine aortic endothelial cells . When the activity of brain and
pituitary FGF on low density HUE cell cultures was compared, both mitogens were active . To
confirm the presence in brain extract of both acidic and neutral, as well as of basic mitogen,
for HUE cells, brain tissues were extracted at acidic (4 .5), neutral (7.2), and basic (8.5) pH .
The three types of extracts were equally potent in supporting the proliferation of either HUE
or adult bovine aortic endothelial cells . When the various extracts were absorbed at pH 6.0
on a carboxymethyl Sephadex C-50 column, the neutral and basic extracts had an activity
after adsorption similar to that of unadsorbed extracts . In contrast, extracts prepared at pH
4 .5 lost 90-95% of their activity which was recovered in the adsorbed fraction containing
FGF .
In 1974 we described the presence in extracts ofbovine brain
and pituitary of a potent mitogen for mouse 3T3 fibroblasts
(1) . This activity was named fibroblast growth factor (FGF).'
Both pituitary and brainFGF were later characterized as basic
molecules with a pI of 9.6 (2, 3). Both of these factors had
common biological activity for a variety of cultured cells
derived from the mesoderm (reviewed in references 4-6) . In
1975, we reported that brain and pituitary tissues contain, in
addition to those basic mitogens, neutral or acidic growth
'Abbreviations used in this paper:
￿
ABAE, adult bovine aortic en-
dothelial ; BCE, bovine corneal endothelial ; DME, Dulbecco's modi-
fied Eagle's medium ; ECGF, endothelial cell growth factor; ECM,
extracellular matrix ; FGF, fibroblast growth factors; HUE, human
umbilical endothelial .
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factors which were given the generic name of myoblast growth
factor(s), since it was with that cell type that these activities
were first detected (7) . While the FGF mitogenic activity is
extracted preferentially at pH 4.5 (1-3, 7), the neutral or acid
activity responsible for increased myoblast proliferation was
best extracted at either neutral or basic pH (7).
Both pituitary and brain FGF stimulate the proliferation of
vascular endothelial cells derived from either bovine aorta
(ABAE cells) or human umbilical vein (HUE cells) (8-10).
Their effects on these two cell types differ somewhat . ABAE
cells maintained on plastic respond optimally to pituitary or
brain FGF when exposed to serum-supplemented medium
(8, 9). In contrast, HUE cells maintained on plastic and
exposed to serum-supplementedmedium require the presence
of thrombin to respond to low concentration ofFGF (10) .
1677The effect of FGF on the proliferation ofhuman vascular
endothelial cells, as well as the nature of the factor involved,
have been questioned (11-13). Maciag et al . have reported
that pituitary FGF at high concentration, and regardless of
whether or not thrombin is present, has no effect on the
proliferation ofHUE cells (11, 12). Thomas et al . (13) have
reported that brain FGF extracted at acidic pH contains an
acidic contaminant that contains all of the activity, whereas
the basic component has none (13). In contradiction to those
earlier studies, the same group (Lemmon et al ., 14) has
reported recently that highly purified preparation of brain
FGF (FGF-A) does indeed consist of basic mitogen, whereas
partially purified preparations (FGF-B) contain, in addition
to the basic component, an acidic factor. It was reported that
while highly purified brain FGF is not very active in stimu-
lating the, proliferation of HUE cells, the partially purified
preparation is more active, and pituitary FGF, which contains
only basic element(s), is inactive (14) .
In view ofthe discrepancy between our early report on the
activity of brain and pituitary FGF in supporting HUE cell
proliferation (10) and recent reports (11-14), we have re-
evaluated the ability ofbrain and pituitary FGF to stimulate
the proliferation of HUE cells . We have compared their
activity with that ofendothelial cell growth factor (ECGF), a
mitogen reported to support the proliferation of HUE cells
(11, 12, 14) and commercial preparations of pituitary FGF
(Collaborative Research, Inc., Lexington, MA ; CR-FGF),
which has been reported by others not to support the prolif-
eration ofHUE cells (11, 12).
MATERIALS AND METHODS
Materials :
￿
Laminin was purified from EHS sarcoma, as described by
Timpl et al . (15). Fibronectin was purified from bovine plasma as described by
Engvall et al . (16). Whenanalyzed byslab gel polyacrylamide gel electrophoresis
under reduced conditions, the purified bovine plasma fibronectin ran as a
doublet with a molecular weight in the range of220,000, while laminin gave
two bands with molecular weights of -200 and 400,000, respectively . Car-
boxymethyl Sephadex C50 was from Pharmacia, Inc. (Piscataway, NJ) . Albu-
min was obtained from Schwarz-Mann (Orangeburg, NJ). Gelatin and dextran
T-40 were obtained from Sigma Chemical Co . (St. Louis, MO) . Collagenase
(CLS grade, 141 U/mg) was from Worthington Biochemical Corp . (Freehold,
NJ). Dulbecco's modified Eagle's medium (DME) and medium 199 (Hanks'
salt formulation) were obtained from GIBCO Laboratories (Grand Island, NY) .
Calfserum and fetal calfserum were obtained from Hy Clone (Sterile Systems,
Inc ., Logan, UT). Tissue culture dishes were from Falcon Plastics, Gentamicin
from ScheringCo . (Kenilworth, NJ), and Fungizone from E. R. Squibb & Sons
(Princeton, NJ) .
Mitogen Preparation :
￿
CR-ECGF (lot 82-356) was purchased from
Collaborative Research, Inc. Pituitary FGF was purifiedaspreviously described
(2, 3, 17), with the following modifications . Ion exchange chromatography was
done using carboxymethyl cellulose, Whatman CM52 (Whatman Laboratory
Products, Inc ., Clifton, NJ), as described for brain FGF (3, 17) . After lyophili-
zation of the fraction eluting at 0.35 M ammonium formate, the proteins were
further purified by isoelectric focusing as described (17) . When analyzed by
polyacrylamide gel electrophoresis, pituitary FGF gave two closely apposed
bands (Fig . 1). Brain FGF was prepared by isoelectric focusing, as already
described (12) . FGF-2 (Fig. 6B in reference 18) was used in the present study .
When the homogeneity ofthat fraction was analyzedby slab gel electrophoresis,
a single band was observed (Fig. 7 in reference I8) . CR-Pituitary FGF (lots 82-
300and 83-225) wasobtained from Collaborative Research, Inc., and itsactivity
was compared with that of a batch of CR pituitary FGF (lot 748-3) provided
by Dr . T . Maciag (Dept. of Pathology, Harvard Medical School Boston, MA)
in 1978 . This lyophilized sample has been stored in the dark at -20'C with
dessicant for the past 5 yr .
Brain Crude Extract Preparations :
￿
Crude extracts ofbovine brain
performed at pH 4.5, 7 .2, or 8 .5 were prepared as previously described (7). 1
kg of brain was homogenized in 2 liters of a solution of 0.15 M ammonium
sulfate . The pH ofthe extract was then adjusted to pH 4 .5 with 6 N HCl or to
pH 7 .2 or 8 .5 with 6 N NaOH . The homogenates were stirred at 4°C for 90
678
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FIGURE 1
￿
SIDS PAGE of pituitary FGF purified by isoelectric focus-
ing . Samples containing 10 (B), 5 (C), and 2 .5 lag pituitary FGF (D),
respectively were added to a sample buffer composed of 15%
glycerol, 0 .1 M dithiothreitol, 2% SIDS, 75 mM Tris-HCI (pH 6.8), 2
mM phenylmethylsulfonyl fluoride, 2 mM EDTA, 1 mM N-ethyl-
maleimide, and 1 mM iodoacetic acid . Samples were boiled for 3
min and then applied to an exponential gradient (10-18%) poly-
acrylamide slab gel with a 4% stacking gel (17, 18) . Electrophoresis
was performed for 4 h at 20 mA . After electrophoresis, the slab gels
were fixed and stained with silver nitrate as described . The migra-
tion of the samples was compared with that of protein standards
(lane A), which included phosphorylase (M, = 92,500), BSA (M, =
66,000), carbonic anhydrase (M r = 31,000), soybean trypsin inhibi-
tor (M r = 21,500), lysozyme (M, = 14,400), and cytochrome c (Mr
= 12,700) . (A) A similar migration pattern was observed regardless
of whether or not the samples were run under reducing conditions .
min and centrifuged at 20,000 g for 45 min . The supernatants were then
checked for their pH and dialyzed at 4°C overnight against distilled water. To
eliminate insoluble material, the dialyzates were centrifuged and then lyophi-
lized .
Crude extracts of brains prepared at various pH were redissolved in 0 .1 M
Na phosphate (pH 6 .0) and then applied onto a small column (3 ml total
volume) of carboxymethyl Sephadex C-50 equilibrate with the same buffer.
The columns were washed with 20 ml of 0 .l M Na phosphate (pH 6 .0), and
the adsorbed proteins were eluted from the columns with 1 M NaCl in 0.1 M
Na phosphate (pH 6 .0) . The optical density of the collected fractions was
determined in a Beckman spectrophotometer at 280 nm (Beckman Instru-
ments, Inc., Cedar Grove, NJ).
Cell Culture Conditions :
￿
Cultures of bovine corneal endothelial
(BCE) cells were established from steereyes as already described (19, 20). Stock
cultures were maintained on tissue culture dishes inDME supplemented with
10% fetal calf serum, 5% calf serum, 50,ug/ml Gentamicin, and 0.25 ug/ml
Fungizone. Prior to being used, all media were passed through a Millipore filter
(0.2 um ; Millipore Corp ., Bedford, MA). Brain FGF (50 ng/ml) was added
every other day until the cells were nearly confluent . Cultures of ABAE cells
derived from the aortic arch were maintained on tissue culture dishes in DME
supplemented with 10% calf serum, 50 ug/ml Gentamicin, and 0.25 Ag/ml
Fungizone, as previously described (8, 9) . During their growth phase, cultures
were exposed or not to pituitary FGF (20 ng/ml added every other day) or
ECGF (250 Aag/ml, added every other day) . This resulted in three cell popula-
tions, one ofwhich had not been submitted to selective pressure by the use of
growth factors, while the other two could have become either FGF- or ECGF-
dependent. Stock plates of the unselected population were passaged weekly at
a split ratio of 1 :4, while the FGF- or ECGF-selected populations were passaged
weekly at a split ratio of 1 :64. The mouse teratocarcinoma cell line PF-HR-9
was generously provided by Dr . R. Kramer (University of California, San
Francisco, CA). PF-HR-9 cells were maintained on tissue culture dishes in
DME supplemented with 10% fetal calf serum and passaged upon reaching
confluence.
HUE cells were obtained from human umbilical vein by collagenase disso-
ciation, as previously described (10, 21, 22) . The cells were seeded onto 10- or6-cm tissue culture dishes coated with gelatin and fibronectin. Cells were grown
in the presence ofmedium 199 (Hanks salt formulation) buffered with 25 mM
HEPES and supplemented with 10-8 M selenium (acid form), 10% fetal calf
serum, 50 Ag/ml Gentamicin, and 0.25 tug/ml Fungizone . During their growth
phase cultures were exposed or not to pituitary FGF (20 ng/ml added every
otherday) or ECGF (250 tug/ml added every other day). This resulted in three
cell populations, one ofwhich had not been submitted to selective pressure by
the use of growth factors, while the two other cell populations could have
become either FGF- or ECGF-dependent . Stock plates ofthe unselected pop-
ulation were passaged weekly on fibronectin-coated dishes at a split ratio of
1 :2, while the FGF- or ECGF-selected populations were passaged weekly at a
split ratio of 1:12.
That cultured HUE cells were truly vascular endothelial cells was confirmed
by three independent criteria : (a) the presence of Factor VIII antigen, as seen
by immunofluorescence ; (b) the presence of Weibel Palade bodies ; and (c) the
morphology of the cells at confluence, which organized themselves into a
monolayer composed of small, nonoverlapping cells (Fig. 2) .
Coating of Plates with Gelatin, Fibronectin, or Laminin :
￿
To
coat the plates with gelatin, a 2-ml solution of 0.2% gelatin in PBS was added
to 35-mm tissue culture plates . Plates were allowed to sit overnight at 4°C. The
next day, the solution was removed and plateswere washed with PBS . To coat
the plates with fibronectin orlaminin, a 1-ml solution of 100 Ag/ml fibronectin
or 450 tag/ml of laminin was added to 35-mm tissue culture dishes (23, 24).
Plates were left at room temperature for 2 h. The fibronectin or laminin
solution was then removed and plates washed with PBS .
Preparation of Extracellular Matrix-coated Dishes:
￿
For pro-
duction of extracellular matrix (ECM), BCE cells were seeded at an initial
density of 4 x 10 4 cells per 35-mm dish and grown in the presence of DME
supplemented with 10% calfserum, 5% dextran T-40, and brain FGF (20 ng/
ml added every other day) (25-27) . HR-9 cells were seeded at high density (2
x 105 cells per 35-mm dish) on fibronectin-coated dishes. This reinforced the
adhesion of the HR-9 ECM to the plastic substratum. HR-9 cells were grown
in the presence ofDME supplemented with 10% calfserum . Once cultures had
been confluent for 5 (HR-9 cells) or 7 d (BCE cells), the media were removed
and the confluent cultures were washed once with PBS . The cells were then
exposed to 0.02 M NH 40H in distilled water for 5 min, followed by washing
with PBS (28, 29) . This results in the denudation ofthe extracellular matrices
produced by both types of cells. While cellular elements are absent from the
ECM produced by BCE cells (30), little cellular debrisremainsclosely associated
with the HR-9 matrix (28).
Cell Seeding:
￿
Cell monolayers from ABAE orHUE stock plates were
dissociated by exposure (2-3 min, 24°C) to a solution containing 0.9% NaCl,
0.01 M sodium phosphates (pH 7 .4), 0.05% trypsin, and 0.02% EDTA (STV
solution, Difco Laboratories, Inc., Detroit, MI) . When cells rounded up, they
were suspended in DME supplemented with 10% calf serum for ABAE cellsor
HEPES buffered 199 medium supplemented with 10-8 M selenium and 20%
fetal calf serum for HUE cells. An aliquot of the cell suspension was then
counted in a Coulter counter (Coulter Electronics, Inc ., Hialeah, FL) and cells
were distributed at an initial cell density of 2 or 4 x 104 cells per 35-mm dish .
Cell Growth Measurement and Culture Lifetime Deter-
mination :
￿
For cell growth measurements, cells were seeded, as described
above, at an initial density of 2 or 4 x 10 4 cells per 35-mm dish . Various
mitogens or brain extracts were dissolved in DME containing 0.5% BSA, and
aliquots (10 kl per dish) containing the various concentrations of factors
indicated in the figure legends were added to the plates . For growth-rate
determinations, triplicate plates were trypsinized every day or every other day,
and the cells counted in a Coulter counter, For determination of potency of
the various preparations, increasing concentrations (ranging from 0 .1 ng to 100
kg/ml) ofthe factors were added to triplicate plates, and plates were trypsinized
and counted when those exposed to the highest concentration becameconfluent
(ordinarily within 5 to 6 d after seeding) .
RESULTS
Comparison of the Ability of Various Substrates
to Support the Proliferation of HUE Cells
The proliferative response ofHUE cells to various mitogens
such as pituitary or brain FGF and ECGF has been reported
to depend on the substrate upon which cells are maintained
(10, 12, 27). Although HUE cells, maintained on plastic,
proliferate poorly in response to serum and pituitary or brain
FGF or ECGF (10, 12), they show a definite improvement in
their ability to respond to these various mitogens when main-
tained on fibronectin- or BCE-ECM-coated dishes (12, 27) .
We have therefore first analyzed the influence of various
substrates on the proliferative response ofHUE cells to serum
factors and pituitary FGF . As shown in Fig. 2A, low density
HUE cell cultures (4 X 10° cells per 35-mm dish) in their first
FIGURE 2
￿
Comparison of the effect of various substratFs on the proliferative response of low density HUE cell cultures to
pituitary FGF . (A) 4 X 104 HUE cells were seeded on either 35-mm plastic tissue culture dishes (P) and coated or not with
fibronectin (Fib), laminin (Lam), HR-9-ECM (HR-9), and BCE-ECM (ECM) . Cells were exposed to HEPES (25 mM) buffered medium
199 supplemented with 10-8M selenium, 20% fetal calf serum, and without (left bar) or with pituitary FGF (right bar F, 10 ng/ml)
added every other day . After 6 d, cultures were trypsinized and cells were counted in a Coulter counter . Standard deviation was
<10%. (B-K) HUE cell cultures were seeded and maintained as described above . Cells were maintained on plastic- (P, B, and C,
fibronectin- (P-Fib, D and E), laminin- (P-Lam, F and G), HR-9-ECM- (H and 1), or BCE-ECM- () and K) coated dishes . Cultures were
exposed to HEPES buffered medium 199 supplemented with 10-8 M selenium, 20% fetal calf serum, and without (B, D, F, H, 1)
or with pituitary FGF (C, E, G, I, and K, 10 ng/ml added every other day) . After 6 d in culture, photomicrographs were taken
under phase-contrast microscopy . X 100 .
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1679passage after primary and maintained on plastic in the pres-
ence of HEPES-buffered medium 199 supplemented with
20% fetal calf serum and antibiotics died over a period of 6
d, as indicated by the final cell density of the cultures, which
was fourfold lower (I .1 x 10° cells per dish) than the seeding
density. In contrast, when pituitary FGF was added to the
culture, cells proliferated actively, so that after a period of 6
d their final cell density was 2.7 x 105 cells per dish. Coating
dishes with either fibronectin or laminin prevented cell death
but had little effect in supporting cell proliferation. Addition
of pituitary FGF to the cultures triggered active cell prolifer-
ation, so that after 6 d in culture the final cell densities were
3.4 and 4.3 x 105 cells, respectively, for cultures maintained
on fibronectin- versus laminin-coated dishes. Cultures main-
tained on fibronectin-coated dishes were more disorganized
and were composed of cells with a larger surface area (Fig. 2,
D and E) than cells maintained on laminin-coated dishes
(Fig. 2, E and G). When the abilities of HR-9-ECM- and of
BCE-ECM-coated dishes to support HUE cell proliferation
were compared, cells not exposed to FGF proliferated mini-
mallywhen maintained on HR-9-ECM but, and as previously
reported (27), proliferated actively on BCE-ECM. In both
cases, addition of FGF to the medium induced rapid cell
proliferation, and the final cell density reached by the cultures
was higher on HR-9-ECM than on BCE-ECM. The morpho-
logical appearance of cells maintained on HR-9 matrix (Fig.
2, Hand I) was that ofsmall and closely apposed cells forming
a uniform monolayer. In contrast, cellsgrown on BCE-ECM-
coated dishes were larger in size (Fig. 2, J and K).
Comparison of the Effect of Pituitary FGF, CR-
FGF, and ECGF on the Proliferation of Low
Density Cultures of HUE and ABAE Cells
HUE cellswere seeded at low density (4 x 10° cells/35-mm
dish) on fibronectin-coated dishes and exposed to medium
supplemented with 20% fetal calf serum and increasing con-
centration of pituitary FGF (ranging from 0.1 ng/ml to 25
ng/ml), CR-FGF (lot 83-225, ranging from 1 ng to 250 ng/
ml), or CR-ECGF (lot 82-356, ranging from 1 ug to 250 ug/
ml). After 5 d in culture, the final cell density of the cultures
was determined. As shown in Fig. 3A, pituitary FGF was
active at concentrations as low as 0.25 ng/ml, at 0.55 ng/ml
half-maximal response was observed, and at 2.5 ng/ml it was
saturating. CR-FGFwas also active, although to a lesser extent
than our preparation. Stimulation of cell proliferation could
be observed readily at 5 ng/ml with a half-maximal effect at
25 ng/ml and saturation at 250 ng/ml. CR-ECGF was also
active. Minimal effects were seen at 5 ug/ml, and saturation
was observed at 100 to 250 ug/ml. That concentration is
40,000-fold higher than that required to observe a maximal
effect of pituitary FGF.
To insure that the above results were not unique to the
HUE cells, we repeated a similar test using ABAE cellsseeded
at low density (2 x 104 cells per 35-mm dish) on plastic dishes
and exposed to medium supplemented with 10% calf serum.
As shown in Fig. 3B, the results were identical to those
observed with HUE cells; the half-maximal response was at
0.4 and 7.5 ng/ml, respectively, for pituitary FGF and CR-
FGF.
Since the activity of CR-FGF could have been limited to
the particular batch we used, we decided to compare the
activity of pituitary FGF to older batches of CR-FGF (lots
680
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FIGURE 3
￿
Effect of increasing concentrations of pituitary FGF, CR-
FGF, and CR-ECGF on the proliferation of low density HUE and
ABAE cell cultures. (A) Low density HUE cells (4 x 104 cells per 35-
mm dish) in their second passage were seeded on fibronectin-
coated dishes and exposed to HEPES (25 mM) buffered medium
199 supplemented with 10-8 M selenium, 20% fetal calf serum and
increasing concentrations of pituitary FGF (PIT-FGF, "), CR-FGF (lot
83-225, O), or CR-ECGF (lot 82-356, O). PIT-FGF or CR-FGF were
added every other day in 10-ul aliquots of medium. Due to the
high concentration tested, CR-ECGF was added in 25-ul aliquots.
After 5 d in culture, triplicate dishes were trypsinized and counted
in a Coulter counter. The crosses indicate the concentrations at
which a half-maximal response was observed for each mitogen.
The final cell density of cultures exposed to 20% fetal calf serum
was 7.2 x 104 cells (arrow, 20% FCS). The inset shows the final
density of HUE cell cultures originally seeded at 4 x 104 cells per
35-mm dish, as described above, and exposed to medium 199
supplemented with 20% fetal calf serum alone (a) or supplemented
with 10 ng/ml pituitary FGF (b), 100 ng CR-FGF (lot 748-3) (c), or
250 mg CR-ECGF (lot 82-300) (d). (8) Low density ABAE cells (2 x
104 cells per 35-mm dish) were seeded on plastic dishes and
exposed to DME supplemented with 10%calf serum and increasing
concentrations of pituitary FGF (PIT-FGF, 0), CR-FGF (lot 83-225,
O), or CR-ECGF (lot 82-356, O) added every other day, as described
above. After 6 d in culture, triplicate dishes were trypsinized and
cells were counted in a Coulter counter. The crosses indicate the
concentrations at which a half-maximal response was observed for
each mitogen. The final cell density of cultures exposed to 10%
calf serum alone was 1 .1 x 105 cells (arrow, 10% CS). The inset
shows the final cell density of ABAE cells seeded at 2 x 104 cells
per 35-mm dish, as described above, and exposed to DME supple-
mented with 10% calf serum alone (a) or with 10 ng/ml pituitary
FGF (b), 100 ng/ml CR-FGF (lot 748-3) (ç), or 250 ug/ml CR-ECGF
(lot 82-300) (d).
82-356 and 734-3), one ofwhich we received from Dr. Maciag
in 1978 (lot 734-3). This particular batch of FGF was just as
active in stimulating HUE cell proliferation as the newly
acquired batch of CR-FGF (Fig. 3A, inset), and it had a
similar effect when tested for its ability to support the prolif-
eration of low density ABAE cell cultures maintained on
plastic and exposed to 10% calf serum (Fig. 3B, inset). CR-
FGF lot 82-356 was 80% as active as lot 83-225 when tested
on both cell types (unpublished results).Comparison of the Ability of FGF and ECGF to
Stimulate the Proliferation of Vascular Endothelial
Cell Cultures Previously Maintained in Their
Presence or Absence
Endothelial cell cultures used in the above studies were
exposed from the beginning oftheir in vitro life span to either
brain or pituitary FGF. The possibility therefore exists that
their ability to respond to FGF reflects the selection of a
subset of endothelial cells particularly responsive to that fac-
tor.
To analyze this possibility, primary cultures of HUE and
ABAE cells were grown either in the total absence of growth
factors or in the presence of either pituitary FGF or ECGF.
The response of the three cell populations in their second
passage after primary to either pituitary FGF or ECGF was
then analyzed. As shown in Fig. 4, low density cultures of
HUE or ABAE cells that have never been exposed to growth
factors in the initial stage oftheir in vitrolife span did respond
to either FGF or ECGF (Fig. 4, A and D). The proliferative
response as a function of growth factor concentration was
similar to that observed with cell populations previously
grown in the presence of either ECGF (Fig. 4, B and E) or
FGF (Fig. 4, C and F). Since cells grown in the absence of
growth factors responded equally well to FGF or ECGF, it is
unlikely that exposing endothelial cells to either mitogen
would select for a subset populationthat would be responsive
to either FGF or ECGF during primary or early-passage
culture.
Comparison of the Ability of Brain and Pituitary
FGF to Stimulate HUE Cell Proliferation
It has been proposed that the mitogenic activity present in
brain FGF that stimulates HUE cell proliferation is caused by
an acidic contaminant (13). We have recently reported the
purification by isoelectric focusing of brain FGF (18). All of
the activity focused in the basic range (pI 9.4 to 9.6), excluding
the possibility ofan acidic contaminant in those preparations
that have been shown to be active in promoting the growth
ofABAE cells (18). To see ifbrain FGF is also active on HUE
cells, we compared its ability to stimulate HUE cell prolifer-
ation with that of pituitary FGF. As shown in Fig. 5A, a
mitogenic effect of brain FGF was readily detectable at 1 ng/
ml, with half-maximal response at 5 ng/ml and saturation at
20 ng/ml. When its activity was compared with that of
pituitary FGF, it was sixfold less active. The effects of brain
and pituitary FGF on the growth rate of low density, first-
passaged HUE cells (2 x 10° cells) maintained on plastic and
exposed to medium supplemented with 20% fetal calf serum
alone was also analyzed, and is shown in Fig. 5 B. Low density
HUE cell cultures (first passage) maintained on plastic and
exposed to serum-supplemented medium alone had a pro-
gressive decline (90%, over a period of 12 d) in their initial
cell density. In contrast, cultures exposed to either brain or
pituitary FGF divided actively (averaging doubling-time of48
h) and by day 10 had a 10-fold increase in cell density. Due
to cell death in cultures maintained in absence of FGF, the
density of cultures exposed to pituitary or brain FGF were
100-fold higher after 12 d in culture than in their absence
(Fig. 5B).
Early-passage (Pz) HUE cells seeded on fibronectin-, BCE-
ECM-, or HR-9-ECM-coated dishes also responded to the
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FIGURE 4
￿
Comparison of the effects of pituitary FGF and ECGF on
the proliferative response of HUE and ABAE cells previously cul-
tured in the presence of serum alone or serum supplemented with
either FGF or ECGF. First-passage HUE cells previously grown in
presence of medium supplemented with serum (A) or with serum
and either ECGF (8) or FGF (C) were seeded at low density (4 x
10° cells) on 35-mm fibronectin-coated dishes. (A-C) Cells were
exposed to HEPES (25 mM) buffered medium 199 supplemented
with 10-8 M selenium, 20% fetal calf serum, and increasing concen-
trations of pituitary FGF (*; ranging from 0.1 to 25 ng/ml) or ECGF
(0; lot 82-356, ranging from 1 to 100 Ag/ml). Mitogens were added
every other day. After 5 d in culture triplicate dishes were trypsin-
ized and counted in a Coulter counter. The final cell density of
cultures exposed to 20% fetal calf serum was 6.4 x 10° cells for
cultures not previously exposed to mitogens (A) and 9.4 (13) or 1 .6
x 105 cells (C), respectively, for cultures previously exposed to
either ECGF or FGF. First-passage ABAE cells previously grown in
presence of medium supplemented with serum (D) or with serum
and either ECGF (E) or FGF (F) were seeded at low density (2 x 10"
cells) on 35-mm plastic tissue culture dishes. (D-F) Cells were
exposed to DME supplemented with 10% calf serum and increasing
concentrations of pituitary FGF (9; ranging from 0.1 to 25 ng/ml) or
ECGF (0; lot 82-356, ranging from 1 to 200 tag/ml). Mitogens were
added every other day, and after 5 d in culture triplicate dishes
were trypsinized and counted in a Coulter counter. The final cell
density of cultures exposed to 10%calf serum was 6 x 10^ cells for
cultures not previously exposed to mitogens (D) and 1 .6 (E) or 1 .2
x 105 cells (F), respectively, for cultures previously exposed to
either ECGF or FGF.
addition ofthe mitogens with an increased growth-rate (24 h
average doubling time during the logarithmic growth phase).
Control cultures maintained on fibronectin- or BCE-ECM-
coated dishes and exposed to 20% fetal calf serum showed a
slow increase in cell density (72 h average doubling time) (Fig.
5B). Cultures maintained on HR-9-ECM-coated dishes did
not proliferate (Fig. 5B).
Comparison of the Ability of Crude Brain Extracts
Prepared at Acidic, Neutral, and Basic pH to
Stimulate the Proliferation of Low Density
HUE Cell Cultures
We have previously shown that brain crudeextract prepared
at acidic pH (pH 4.5) contains mostly basic mitogen(s) such
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168 1as FGF, while those prepared at neutral (pH 7.2) or basic pH
(pH 8.5) contains mostly neutral or acidic mitogens (7). We
have therefore compared the activity of those brain extracts
on the proliferation of low density HUE cells (4 x 104 cells
per 35-mm dish) seeded on fibronectin-coated dishes. As
shown in Fig. 6, when those extracts were tested at concentra-
tions ranging from 1 to 250 gg/ml, they were equally active
in stimulating the proliferation of HUE cells. This tends to
demonstrate that the basic mitogens that predominate in
acidic extract are as potent in stimulating HUE cell prolifer-
ation as neutral or acidic mitogens predominating in neutral
or basic extract. To determine further whether basic mitogens
are mostly present in acidic extract whereas neutral or acidic
ones are present in neutral and basic extract, all three types
of extract were dissolved in 0.1 M Na phosphate, pH 6.0 and
then applied on a carboxymethyl Sephadex C50 column. The
unadsorbed proteins and the adsorbed fraction eluted with 1
M NaCl in 0.1 M Na phosphate (pH 6.0) were then tested for
theirability to stimulatethe proliferation oflow densityABAE
cells (2 x 104 cells/35-mm dish) maintained on plastic. The
elution profile ofeach extract is shown in "ihe insets ofFig. 6.
The unadsorbed fraction of the pH 4.5 brain crude extract
was 10-fold less potent than the input; while the adsorbed
fraction, presumably containing FGF, was 20-fold more po-
tent than the input (saturation at 2.5 ug protein/mlversus 50
,ug protein/ml for the input). In contrast with both crude
extracts prepared at either pH 7.2 or 8.5, ;chromatography
onto a carboxymethyl Sephadex column did not decrease
.05 .I
I
682
￿
THE JOURNAL Or CELL BIOLOGY " VOLUME 97, 1983
their activity. On the contrary, the unadsorbed fractions were
as active (pH 7.2) or more active (pH 8.5) than the input.
The adsorbed fractions eluting with 1 M NaCl contained so
little protein that it could not be tested for activity. It is
therefore likely that most of the activity (90-95%) present in
the acidic brain extract is due to basic mitogens which would
be adsorbed on the carboxymethyl Sephadex column, whereas
that present in neutral or basic extract is composed of neutral
or acidic protein that would not be adsorbed onto the column.
DISCUSSION
The present results emphasize the role ofbovine pituitary and
brain FGF in the in vitro control of proliferation of vascular
endothelial cells. As reported in 1977, both pituitary and
brain FGF are mitogenic for human and bovine vascular
endothelial cells (4, 8-10), and in both cases the substrate
upon which the cells are maintained plays an important role
in the cells' response to the mitogens. Bovine vascular endo-
thelial cells maintained on plastic and exposed to serum-
supplemented media respond to FGF with an increased pro-
liferative rate (4, 8, 9). Maintenance of the same cells on the
ECM produced by cultured BCE cells will allow the cells to
proliferate in the absence of FGF at an optimal rate (average
doubling time 18 h) in response to plasma factors (28). These
factors are likely to be transferrin and high density lipopro-
teins, which together support the growth of ABAE cells ex-
posed to serum-free medium (31).
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FIGURE 5
￿
Proliferation as a function of concentration of brain and pituitary FGF and as a function of time of early passage HUE
cells maintained on plastic, fibronectin-, BCE-ECM-, or HR-9-ECM-coated dishes and exposed or not to pituitary or brain FGF.
(A) Low density HUE cells (4 x 104 cells per 35-mm dish) in their first passage after primary and previously grown in the presence
of pituitary FGF were seeded on fibronectin-coated dishes and exposed to 25 mM HEPES buffered medium 199 supplemented
with 10-8 M selenium, 20% fetal calf serum, and increasing concentrations of pituitary FGF (PIT-FGF, 0) or brain FGF (p). Both
mitogens were added every other day. After 5 d in culture, triplicate dishes were trypsinized and counted in a Coulter counter.
The crosses indicate the concentration at which a half-maximal response was observed for each mitogen. The final cell density
of HUE cell cultures exposed only to 20% fetal calf serum was 6 x 104 cells per plate (arrows, 20% FCS). (B) Low density HUE
cells (2 x 104 cells per 35-mm dish) in their first passage after primary and previously grown in the presence of pituitary FGF
were seeded on plastic (PLAST), fibronectin (PLAST-FIB), BCE-ECM-, or HR-9-ECM-coated 35-mm dishes and exposed to 25 mM
HEPES buffered medium 199 supplemented with 10-8 M selenium, 20% fetal calf serum alone (p) or with brain FGF (50 ng/ml,
,L) or pituitary FGF (10 ng/ml, ") added every other day. Triplicate dishes were trypsinized every other day and counted in a
Coulter counter.10
X
t_n
W
J
w
U
9r A pH 4.5
8
7
6
5~-
I/
41--
0-e~e
B pH 7.2
5 Io 5 Io
FRACTION NO. ~--~ SEEDING 1
￿
I
￿
I
￿
I
￿
I
￿
I
￿
I
￿
I
.5
￿
1
￿
5
￿
10
￿
25 50 100 250 .5
￿
1
￿
5
￿
10
￿
25 50 100 250
￿
.5
￿
1
￿
5
￿
10 25 50 100 250
Human vascular endothelial cells, which are far more dif-
ficult to culture than bovine cells, have a similar substrate
requirement for optimal proliferation in response to serum
factors and exogenous growth factors. On plastic, early-pas-
sage HUE cells seeded at low density did not proliferate
actively. The survival of HUE cells was greatly increased
when the plastic surface was coated with various agents such
as fibronectin, laminin, or biomatrices produced by either
HR-9 or BCE cells. On all these substrata, HUE cells re-
sponded to the addition of pituitary or brain FGF by prolif-
erating actively.
Ofall substrata tested, cells were best organized at conflu-
ence when maintained on laminin- or HR-9-ECM-coated
dishes. In both cases, pituitary or brain FGF was required for
HUE cells to proliferate actively. In contrast, more disorga-
nized cultures maintained on either fibronectin- or BCE-
ECM-coated dishes was observed. In this regard, it is worth
noting that the HR-9 matrix, which is composed mostly of
collagen type IV, heparin sulfate proteoglycans, laminin, and
entactin (32-34) has a composition very close to that seen in
vivo in capillary endothelial cell basement membrane (35,
36). In contrast, the BCE-ECM (on which HUE cells are more
disorganized) contains, in addition to the components present
in the HR-9 matrix, elastin, collagen type I and III, fibronec-
tin, and dermatan sulfate proteoglycans (37-39). These addi-
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FIGURE 6
￿
Effects of increasing concentrations of crude brain extracts prepared at pH 4.5, 7.2, or 8.5 and chromatographed on
carboxymethyl Sephadex C-50 column on the proliferation of low density HUE cells. Brain crude extracts were prepared as
described in Materials and Methods and reference 7. 20 mg of lyophilized extract was dissolved in 2 ml of 0.1 M Na phosphates
buffer, pH 6.0 and applied on a small (3 ml total volume) column of carboxymethyl Sephadex C-50. The column was washed
with 0.1 M Na phosphates pH 6.0, as described (2, 3, 17). 1-ml fractions were collected and their optical density at 280 mm was
determined (inset). Protein concentration was determined on the basis of an extinction coefficient of E,C' . = 0.8. After adequate
dilution of the unadsorbed and adsorbed fractions with DME, aliquots (10 II) containing the various protein concentrations were
then added every other day to low density ABAE cells (2 x 10" cells per 35-mm dish, arrow SEEDING) maintained on plastic
dishes and exposed to DME supplemented with 10% calf serum. After 6 d in culture, triplicate dishes were trypsinized and cells
counted in a Coulter counter. The cell density of control cultures exposed to 10% calf serum was 1 .2 x 105 cells after 6 d (arrow,
10% CS) . (A) Crude extract prepared at pH 4.5: 0, crude extract; A, unadsorbed fraction;*, adsorbed fraction. Inset shows the
chromatographic profile (left) of the unadsorbed fraction, and the elution profile ofthe adsorbed fraction (right). (B) Crude extract
prepared at pH 7.2 : 0, crude extract; A, unadsorbed fraction . (C) Crude extract prepared at pH 8.5: 0, crude extract; A,
unadsorbed fraction.
tional components could be responsible for the disorganiza-
tion of the confluent cultures. As reported earlier (10), we
have been able to passage HUE cell cultures weekly at a split
ratio of 1 :10 using either BCE or HR-9 matrix for at least 50
doublings. FGF is required to observe an optimal growth rate.
Although on BCE-ECM increased cellular pleiomorphism as
a function of passage number was observed, this was less
obvious in the case of cultures maintained on HR-9 matrix
(unpublished results).
In previous studies we reported that HUE cellsmaintained
on plastic respond poorly to FGF and require the presence of
thrombin to respond optimally (10). In the present study, we
have observed that coating the plastic surface with fibronectin
markedly improved the response of the cells to FGF. This
raises the possibility that thrombin, which has no intrinsic
ability to stimulate HUE cell growth (4, 10), may act in a
manner similar to that of fibronectin.
In our hands, CR pituitary-FGF is 1,000- and 20-fold more
potent as a mitogen for low density HUE cell cultures than
crude (11, 12) or partially purified ECGF preparation (12,
40). The mitogenic activity of CR-FGF, observed with newly
acquired preparations, was also shared by older preparations
provided by Dr. Maciag. Although it is conceivable that the
early negative results obtained with pituitary FGF (11) could
have been caused by the plastic substrate on which cellswere
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used (12),and FGF preparations obtained either from Collab-
orative Research or purified by Lemmon et al. (14) remained
inactive. One possible explanation for the lack of activity of
FGF on these cells could be that stock cells were grown in the
presence of ECGF (12, 14). This factor could have caused a
down-regulation of FGF binding sites similar to the down-
regulation of EGF binding sites observed when cells are
exposed to either platelet-derived growth factor (PDGF) or
FGF (41-44), and thereby could have made the cells FGF-
resistant. This possibility has been analyzed in the present
study by looking at the proliferative response to FGF and
ECGF of endothelial cell populations that have never been
exposed to growth factors other than those present in serum
versus the response of populations previously exposed to
either FGF or ECGF. It is clear from our results that possible
selection of vascular endothelial cells resulting from growing
primary cultures in the presence of FGF does not make them
resistant to ECGF. The converse is also true. Growing cells in
the presence of serum alone does not seem to select for cell
populations that do not respond to either FGF or ECGF. It
is possible, however, that unselected cell populations grown
in the presence of a given growth factor could develop an
addiction for that growth factor when passaged repeatedly at
low density. This would not, however, prevent them from
respondingto other growth factors, since early- or late-passage
ABAE cells grown continuously in the presence of FGF
respond equally well to ECGF when exposed to it (Figs. 3 and
4). Likewise, fibroblast, granulosa, vascular smooth muscle,
and corneal endothelial cells continuously grown in the pres-
ence of FGF can respond equally well to EGF (4).
The possibility has been raised that the mitogen active in
FGF preparation is an acidic contaminant (13) similar in
nature to ECGF (12), Since both pituitary and brain FGF
used in the present study have a pl of 9.6 (17, 18), the
possibility that an acidic contaminant could be involved in
the mitogenic activity of FGF has been eliminated. This does
not mean, however, that neutral or acid mitogens cannot
trigger the proliferation of HUE cells. We have previously
reported that the proliferation ofHUE cellscould be triggered
both by FGF (a basic mitogen) and by EGF (an acidic
mitogen). The action of both mitogens could be potentiated
by thrombin (10). In 1975, we also reported the presence of
mitogen(s) in both brain and pituitary extracts prepared at
either neutral or basic pH that were shown by their chro-
matographic behavior on DEAE and carboxymethyl Sepha-
dex column to be either neutral or acidic (7). While basic
mitogens are best extracted at acidic pH (4,5), the neutral and
acidic ones are best extracted at neutral (7.2) or basic pH (8.5)
(7). This situation is reminiscent of what occurred with pitui-
tary hormones, which have solubilities that vary with the pH
of extraction. In 1961, Ellis (45), in what was considered to
be a classic paper, described the sequential extraction of
bovine pituitary glands with waterat pH 5.5, 0.1 M (NH4)2SO4
at pH 4.0, 0.25 M (NH4)2SO4 at either pH 5.5 or 7.5, and
finally with 50% ethanol at pH 9.8 to 10. The extracts were
bioassayed for the anterior pituitary hormones and for the
proteinases I and II. With certain exceptions, the first extract
contained mainly follicle stimulating hormone and proteinase
I; the second, luteinizing hormone and thyroid stimulating
hormone; the third growth hormone and proteinase 11; and
the fourth, prolactin. These methods of extraction are com-
monly used for the purification of the various pituitary hor-
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mones (46, 47). It is also worthwhile to observe that FGF (a
basic mitogen) is commonly found as a contaminant in
preparations of LH (48), a hormone that, according to Ellis
(45), is preferentially solubilized at pH 4.0, but not in either
growth hormone or prolactin preparations (7), which are
extracted at neutral or basic pH. Our previous studies dealing
with the solubility of mitogens at different pH (7) have
recently been confirmed by others (49), who have reported
that acidic or neutral mitogens are insoluble when pituitary
tissue is extracted at an acidic pH of 4,5. In the present study,
we have confirmed that neutral or acidic mitogens extracted
at either neutral or basic pH and first shown to be active on
myoblasts are also active on HUE cells. It is likely that they
are the same as the recently identified ECGF which is purified
from neutral (pH 7.2) extract of hypothalamus (40).
In conclusion, just as in a previous study (18) we were
unable to confirm the existence of an acidic contaminant in
brain FGF, in the present study we were unable to confirm
that pituitary FGF is not mitogenic for human umbilical vein
endothelial cells. On the contrary, using unselected cell pop-
ulations, we have observed that FGF was even more active
on HUE cells than on bovine vascular endothelial cells.
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